The Protein Neddylation Inhibitor MLN4924 Suppresses Patient-Derived Glioblastoma Cells via Inhibition of ERK and AKT Signaling

Glioblastoma is a highly aggressive and lethal brain tumor, with limited treatment options. Abnormal activation of the neddylation pathway is observed in glioblastoma, and the NEDD8-activating enzyme (NAE) inhibitor, MLN4924, was previously shown to be effective in glioblastoma cell line models. How...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Suji, Shin, Hyemi, Oh, Jeong-Woo, Oh, Yun Jeong, Her, Nam-Gu, Nam, Do-Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966592/
https://www.ncbi.nlm.nih.gov/pubmed/31771104
http://dx.doi.org/10.3390/cancers11121849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966592/
https://www.ncbi.nlm.nih.gov/pubmed/31771104
http://dx.doi.org/10.3390/cancers11121849

Ejemplares similares